Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma

Authors:

Abstract
No abstract available
Funding Information
  • McMaster University
  • Hamilton Health Sciences
  • CIHR

This publication has 81 references indexed in Scilit: